Executive Team

Mee Eriksson

CEO, NeuroTechR3, Inc.

Mrs. Eriksson co-founded NeuroTechR3 Inc. with the vision to transform the rehabilitation sector by offering affordable and accessible AI-driven therapy solutions for people with various neurological conditions. As a 100% women-owned business, she is committed to serving as an inspiring figure and role model for other women in technology and entrepreneurship.

With over 20 years of international experience in project management and business management, Mrs. Eriksson has expertise in strategic planning, business development, organizational growth, marketing, fundraising, and program development across diverse industry segments and non-profit organizations.

She is the Principal Investigator (PI) on three federal R&D grants awarded in consecutive years from 2021 to 2023. Being an accomplished team leader with strong management skills in scheduling, cost control, vendor and third-party supplier contracting, makes her exceptionally suited to lead NeuroTechR3’s team of highly specialized researchers and talented tech experts spearheading a new standard of care in neurorehabilitation.

Qinyin Qiu

Chief Science Officer, NeuroTechR3, Inc.

Dr. Qiu is the Chief Science Officer and Co Founder of NeuroTechR3, Inc. As the lead scientist and engineer she oversees all product development and research of the Company. She is responsible for developing research capabilities and communicating with both the scientific and customer communities concerning the capabilities and scientific product offerings. Additionally, she is in charge of scientific discoveries into neural patterns of reorganization, motor skill changes, and virtual reality-augmented rehabilitation.

Dr. Qiu received her Bachelor’s degree in Computer Engineering from China, her Master’s degree in Computer Engineering from University of Southern California, and PhD in Biomedical Engineering from New Jersey Institute of Technology and Rutgers University. Her research background is in gamified, simulation based, robotic assisted rehabilitation system design and development. During this time, she was lead scientist in a large study examining the use of these systems in children with Cerebral Palsy and adults suffering from stroke. Dr. Qiu’s extensive research into neural patterns of reorganization, motor skill changes, and virtual reality-augmented rehabilitation, is essential to developing high performance standards for the company’s devices. Dr. Qiu’s close collaboration with inpatient rehabilitation hospitals, such as Kessler Rehab Institute and St. Joseph’s Wayne hospital, gives her a unique first hand view of market demand on telerehabilitation. Dr. Qiu has authored several peer reviewed publications.

Amanda Gross

Chief Technology Officer, NeuroTechR3, Inc.

It is Mrs. Gross’s personal goal to make transformative, user-friendly technologies accessible to individuals with disabilities. She co-founded NeuroTechR3, Inc. with the mission of developing cutting edge rehabilitation solutions for individuals with neurological impairments, increasing access to neuromotor exercises. As the Chief Technology Officer of NeuroTechR3, her objective is to drive innovation forward, merging technology and rehabilitation. Mrs. Gross is committed to harnessing the latest advancements to create immersive, personalized experiences that empower individuals on their journey to recovery.

Her expertise and passion lie in creating interactive software and games that incorporate both physical and motion sensors. With a solid foundation in both visual and interactive design, Mrs. Gross’s skill set spans computer programming, 2D and 3D game design and development, 3D design, motion graphics, and graphic design. She specializes in the use of cutting-edge technologies and devices, to craft dynamic, interactive software experiences. Her toolkit includes C# and Java programming, development with the Unity 3D game engine, graphical user interface design, asset creation with 3DS Studio Max, and the Adobe Creative Suite.

Ashley Mont

Chief Research Compliance Officer, NeuroTechR3, Inc.

Dr. Ashley Mont is the Chief Research Compliance Officer and Co-Founder of NeuroTechR3, Inc. In her role, she is responsible for designing study protocols and overseeing the evaluation of how studies are conducted to ensure compliance with regulatory standards. She plays a pivotal role in working with academic and healthcare partners to maintain ethical practices across all research activities. Dr. Mont also spearheads efforts to integrate compliance measures into the innovation process, enhancing the integrity and efficacy of the company’s product development.

Ashley earned her B.S. from Rutgers University and her M.S. and Ph.D. from New Jersey Institute of Technology (NJIT) in biomedical engineering. Her research focus at NJIT revolved around developing and evaluating robotic technologies to improve upper limb function post-stroke. Prior to starting her PhD, Ashley worked in the Mercer County Special Services School District, closely engaging with children with disabilities, and also volunteered with adults with disabilities through the Special Olympics of New Jersey. These experiences have driven her passion to develop new technologies that improve care and quality of life for those with disabilities

Scroll to top